Home Home Home Inbox Home Search

Event

The Motion Study to Assess the Effect of Riociguat on Patient-Reported Outcomes in PAH: Correlations Between the Living with Pulmonary Hypertension Questionnaire and Secondary Endpoints [Board No. P126]

Location: Board no. P126
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Anneliese LaRose

MS
Bayer HealthCare Pharmaceuticals Inc

Lana Melendres-Groves

MD
Internal medicine;University of New Mexico

Frank Kleinjung

PhD
Bayer AG

Gerald M. O'Brien

MD
Bayer HealthCare Pharmaceuticals Inc

David M. Platt

MD
Bayer HealthCare Pharmaceuticals Inc

Franck F. Rahaghi

MD
Cleveland Clinic Florida

View Abstract

The Motion Study to Assess the Effect of Riociguat on Patient-Reported Outcomes in PAH: Correlations Between the Living with Pulmonary Hypertension Questionnaire and Secondary Endpoints

Parent Sessions

  • A64 - LET'S GO TRIPPIN': DIAGNOSTICS AND RISK ASSESSMENT IN PULMONARY HYPERTENSION...
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search